✦ LIBER ✦

Evidence for common genetic control in pathways of inflammation for Crohn's disease and psoriatic arthritis

✍ Scribed by Pauline Ho; Ian N. Bruce; Alan Silman; Deborah Symmons; Bill Newman; Helen Young; Christopher E. M. Griffiths; Sally John; Jane Worthington; Anne Barton

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 82 KB
Volume: 52
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.21393

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lack of support for a common etiology in

Lack of support for a common etiology in Johne's disease of animals and Crohn's disease in humans

✍ Dr. Herbert J. Van Kruiningen 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 947 KB

The superficial similarity of Johne's disease to Crohn's disease led to the hypothesis that, like the former, Crohn's disease was caused by Mycobacterium paratuberculosis. Detailed pathologic comparisons, however, reveal little similarity between these two entities, including the lack of important e

Alternative processing of γ-secretase su

Alternative processing of γ-secretase substrates in common forms of mild cognitive impairment and alzheimer's disease: Evidence for γ-secretase dysfunction

✍ Saori Hata; Sayaka Fujishige; Yoichi Araki; Miyako Taniguchi; Katsuya Urakami; E 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB 👁 1 views

Objective: The most common pathogenesis for familial Alzheimer's disease (FAD) involves misprocessing (or alternative processing) of the amyloid precursor protein (APP) by c-secretase due to mutations of the presenilin 1 (PS1) gene. This misprocessing/alternative processing leads to an increase in t

Comparison of two dosing methods for ind

Comparison of two dosing methods for induction of response and remission with oral budesonide in active pediatric Crohn's disease: A randomized placebo-controlled trial

✍ Arie Levine; Michal Kori; Gabriel Dinari; Efrat Broide; Ron Shaoul; Baruch Yerus 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 4 views

## Background: Oral budesonide has been found to be comparable to systemic corticosteroids in mild to moderately active crohn's disease (cd). remission rates in pediatric studies to date have been suboptimal (47%-55%), even though patients with colonic involvement were excluded in some studies. in